Polar Asset Management Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,589	Closed	-$238K	–	1261
2021 Q3	$238K	Buy	+16,589	New	+$238K	﹤0.01%	899